![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 28, 26036-26043, July 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the We have studied T-cell protein-tyrosine
phosphatase (TCPTP) as a model phosphatase in an attempt to unravel
amino acid residues that may influence the design of specific
inhibitors. Residues 48-50, termed the YRD motif, a region that is
found in protein-tyrosine phosphatases, but absent in dual-specificity
phosphatases was targeted. YRD derivatives of TCPTP were characterized
by steady-state kinetics and by inhibition studies with BzN-EJJ-amide,
a potent inhibitor of TCPTP. Substitution of Asp50 to
alanine or Arg49 to lysine, methionine, or alanine
significantly affected substrate hydrolysis and led to a substantial
decrease in affinity for BzN-EJJ-amide. The influence of residue 49 on
substrate/inhibitor selectivity was further investigated by comparing
subsite amino acid preferences of TCPTP and its R49K derivative by
affinity selection coupled with mass spectrometry. The greatest effect
on selectivity was observed on the residue that precedes the
phosphorylated tyrosine. Unlike wild-type TCPTP, the R49K derivative
preferred tyrosine to aspartic or glutamic acid. BzN-EJJ-amide which
retains the preferred specificity requirements of TCPTP and PTP1B was
equipotent on both enzymes but greater than 30-fold selective over
other phosphatases. These results suggest that Arg49 and
Asp50 may be targeted for the design of potent and
selective inhibitors of TCPTP and PTP1B.
The YRD Motif Is a Major Determinant of Substrate and Inhibitor
Specificity in T-cell Protein-tyrosine Phosphatase*
§,
,
,
,
,
,
, and
Department of Biochemistry and Molecular
Biology and the ¶ Department of Medicinal Chemistry, Merck
Frosst Center for Therapeutic Research, Pointe-Claire-Dorval H9R 4P8,
Canada and the
Department of Endocrinology and Cell Biology,
Merck Research Laboratory, Rahway, New Jersey 07065
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
K. Hellmuth, S. Grosskopf, C. T. Lum, M. Wurtele, N. Roder, J. P. von Kries, M. Rosario, J. Rademann, and W. Birchmeier Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking PNAS, May 20, 2008; 105(20): 7275 - 7280. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Asante-Appiah, S. Patel, C. Desponts, J. M. Taylor, C. Lau, C. Dufresne, M. Therien, R. Friesen, J. W. Becker, Y. Leblanc, et al. Conformation-assisted Inhibition of Protein-tyrosine Phosphatase-1B Elicits Inhibitor Selectivity over T-cell Protein-tyrosine Phosphatase J. Biol. Chem., March 24, 2006; 281(12): 8010 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Montalibet, K. Skorey, D. McKay, G. Scapin, E. Asante-Appiah, and B. P. Kennedy Residues Distant from the Active Site Influence Protein-tyrosine Phosphatase 1B Inhibitor Binding J. Biol. Chem., February 24, 2006; 281(8): 5258 - 5266. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Torres and M. K. Rosen Protein-tyrosine Kinase and GTPase Signals Cooperate to Phosphorylate and Activate Wiskott-Aldrich Syndrome Protein (WASP)/Neuronal WASP J. Biol. Chem., February 10, 2006; 281(6): 3513 - 3520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lu, C. Zhang, and Z. Zhai Nucleoplasmin regulates chromatin condensation during apoptosis PNAS, February 22, 2005; 102(8): 2778 - 2783. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Walchli, X. Espanel, A. Harrenga, M. Rossi, G. Cesareni, and R. H. van Huijsduijnen Probing Protein-tyrosine Phosphatase Substrate Specificity Using a Phosphotyrosine-containing Phage Library J. Biol. Chem., January 2, 2004; 279(1): 311 - 318. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Romsicki, G. Scapin, V. Beaulieu-Audy, S. Patel, J. W. Becker, B. P. Kennedy, and E. Asante-Appiah Functional Characterization and Crystal Structure of the C215D Mutant of Protein-tyrosine Phosphatase-1B J. Biol. Chem., August 1, 2003; 278(31): 29009 - 29015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Sun, A. A. Fedorov, S.-Y. Lee, X.-L. Guo, K. Shen, D. S. Lawrence, S. C. Almo, and Z.-Y. Zhang Crystal Structure of PTP1B Complexed with a Potent and Selective Bidentate Inhibitor J. Biol. Chem., March 28, 2003; 278(14): 12406 - 12414. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Espanel, M. Huguenin-Reggiani, and R. H. van Huijsduijnen The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities Protein Sci., October 1, 2002; 11(10): 2326 - 2334. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |